Replies to post #163558 on Cytodyn Inc (CYDY)

[Upside08]

Unfortunately your perspective is entirely wrong. Where does it say 28 patients in Brazil? It’s 1500 in total. I would buy today prior to the call.

[daemon57]

Tiger (trader) can't change it's stripes, eh Grip? Buy low sell high, sell (short) high buy low.

The company regardless of what anyone posts is on the move. The question is, who's on for the ride?

GLTU/A.

[Upside08]

Also “true longs”, 12 months or more are making money and are pleased with the progress.

[Itchy palm]

Are you mixing up 28 patients in Philippines with Brazil trial which will have 1,500 in two trials

[TheProfesser]

I now simply add the words “I hope” to the beginning of each of your declarative sentence and get your true intent.

[SF Anony]

Where did you get 28 patient trial?

With approximately 1,500 patients in total for both trials, we anticipate having adequate power in each trial to achieve a significant p-value for our endpoints and will be performing an interim analysis after 40% of the critically ill patients are enrolled.

[DiscusDude]

Appreciate the insight Grip. Thanks for keeping those willing to listen on the right side of the trade. There’s a time to be in and there’s a time for the sidelines. Right now the sidelines continue to be the place to be as the SP looks to be heading nowhere but down.

As expected another (large) trial is required. I wonder what happened to the 200 person critical trial with FDA that Nadar was so “thankful” for them to allow. Seems that might also be dust in the wind as well. It’s amazing how often Nadar makes certain scenarios seem like a done deal and then we never hear about them again. Let’s see how the CC goes....